Abstract
The purpose of this study was to first determine if neuromuscular scoliosis results in greater peri-operative transfusion requirements compared to idiopathic scoliosis, and secondly to compare the effects of tranexamic acid (TXA) dosing on reducing transfusion requirements in scoliosis surgery. Previous studies have suggested that patients with neuromuscular scoliosis tend to have more blood loss during scoliosis corrective surgery as compared to patients with idiopathic scoliosis. Tranexamic acid has not been studied extensively in these populations and consensus regarding appropriate dosing has not yet been elucidated. A retrospective chart review of all patients who underwent posterior instrumentation and fusion for scoliosis for the years 1999 to 2006 was performed. Peri-operative transfusion requirements for idiopathic and neuromuscular scoliosis patients were compared and grouped according to TXA use. Transfusion requirements for those patients receiving either a low (10mg/kg loading, 1mg/kg/h infusion) or high (20mg/kg loading, 10mg/kg/h infusion) dose TXA were also compared.
Idiopathic patients had significantly decreased transfusion requirements overall (no TXA: idiopathic 1028.3 ± 558.7ml vs. neuromuscular 1400.7 ± 911.3ml, p = 0.02; with TXA: idiopathic 1082.9 ± 1005.5ml vs. neuromuscular 2043.8 ± 1397.5ml, p = 0.03). In the idiopathic group, high dose TXA resulted in a significant reduction in peri-operative transfusion requirements compared to low dose TXA (687.9 ± 778.1ml vs. 1355.0 ± 965.8ml, p = 0.04).
Neuromuscular scoliosis patients have significantly higher transfusion requirements as compared to idiopathic patients. For patients with idiopathic scoliosis, the use of the high dose TXA is suggested over low dose TXA given the relative reduction in transfusion requirements for the high dose group.
Correspondence should be addressed to: Cynthia Vezina, Communications Manager, COA, 4150-360 Ste. Catherine St. West, Westmount, QC H3Z 2Y5, Canada
